Treatment with low doses of GI254023X causes a mild decrease in ADAM10 surface expression that correlates with a marked impairment of HCV infectivity. by Belén Carriquí-Madroñal (17396512)

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

Nectin-1 staining is decreased in HSV1-infected keratinocytes, but enhanced as a collar in surrounding uninfected cells. by Hafsa Rana (8201886)

Subjects:

Linearity of relationship between age prediction counts and predicted age. by Catherine A. Pruszynski (3749149)

“…All data sets demonstrated a strong, non-linear decrease in the sample count as predicted age increased, indicating suitability of the data for assessment using <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0012350#pntd.0012350.e002" target="_blank">Eq 2</a>.…”

Linearity of ACER3 activity assay. by Jae Kyo Yi (13570063)

The relationships between the mean time to extinction <i>T</i> and the size of the community, <i>N</i>, in different scenarios. by Immanuel Meyer (12306666)

Subjects:

Average (and SE) of the hierarchical linearity measured as the proportion of transitive states for different levels of intensity of aggression. by Erik van Haeringen (12035259)

Subjects:

With increasing age, the FBA increased, then the NSA and the aMDFA increased, which finally led to a decreased mMDFA. by Yang Lu (59885)

Logistic regression analyses for impact of gender, residential area, family system and age on different domains of EPII-A. by Nazish Imran (5280212)

Subjects:

Multiple linear regression analysis across generations in test populations. by Gurpreet Kaur Suri (12106975)

Subjects:

Aging increases senescence markers in ASM. by Sarah A. Wicher (11204226)

“…<p>Immunofluorescence staining for p21 a marker of cell cycle arrest (A) showed increased levels in elderly ASM. γH2AX, a marker for DNA damage, increased in elderly ASM (B). …”

Chance of relapse was increased with increasing Gleason Score, PSA level and age. by Stephanie E. A. Burnell (7164608)

“…<p>(A) Gleason, (B) PSA level and (C) Age were plotted against the death and relapse of the patient. …”

Cyclopropane as an Unsaturation “Effect Isostere”: Lowering the Melting Points in Lipid-like Ionic Liquids by Richard A. O’Brien (1538818)

“…While cyclopropanation of the lipid-like ionic liquids provides more resistance to aerobic degradation than their olefin analogs, the impact on the melting point decrease is not as pronounced. Our results demonstrate that incorporating one or more cyclopropyl moieties in long aliphatic chains of imidazolium-based ionic liquids is highly effective in lowering the melting points of such materials relative to their counterparts bearing linear, saturated, or thioether side chains. …”

Effect of sorafenib alone or added to hesperetin on the expression of NLRP3 inflammasome and TLR4 via western blotting in different groups. by Dalia Zaafar (6693017)

Linear regression model with MBI score. by Nadia Yanet Cortés-Álvarez (18611445)

Loss of Prox1a decreases PR production at 120 hours post-ablation. by Kellie Veen (17343374)

Given a linear growth trajectory, increasing survival increases optimal maturation age and size. by James E. Breck (8582229)

“…<p>As annual survival <i>s</i> increases, the growth curve is unchanged, but the iso-fitness curves become less steep and the age-0 intercepts increase (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0228990#pone.0228990.g008" target="_blank">Fig 8</a>), so optimal age and length increase along the growth curve. …”

Serum levels of anti-PspA IgG with increasing age. by Adriano P. Araujo (10136683)

Serum levels of anti-PspC IgG with increasing age. by Adriano P. Araujo (10136683)

Finishing time increases with age. by Shawn E. Bearden (21354500)